No investor likes it when a potential buyout deal for one of their holdings hits a serious roadblock. This is apparently ...

After a dreadful 2024 that saw its stock lose more than 60% of its value, 2025 has started off as a better year for Walgreens ...

Salesforce’s growth story remains compelling, with projected revenue growth of 17% in 2025 and strong demand for AI-driven ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...

The S&P 500 (\^GSPC 0.88%) has been on fire for the last two years, racking up a gain of nearly 51%, which it hadn't done ...

The S&P 500 plunged 1.5% on Friday, Jan. 10, as an unexpected surge in hiring in the December jobs report raised concerns ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elevance Health (ELV – Research Report), Intuitive Surgical ...

We recently published a list of 10 Stocks Nosedive, Defying Broader Optimism. In this article, we are going to take a look at ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine. The financial package will fund the expansion of ...

Returning 25% in 2024, the S&P 500 delivered a record-breaking year for stock market investors. A resilient global economy ...

Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had [recently bought another $1.1 billion of bitc ...